Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.26
+0.41%
Mkt Cap $411.94M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$12.00
Range $11.00 – $13.00
Implied Upside
+65.3%
Consensus $12.00 vs current $7.26